| Literature DB >> 26730392 |
Nathan D Grubaugh1, Aaron Massey2, Katherine D Shives3, Mark D Stenglein1, Gregory D Ebel1, J David Beckham4.
Abstract
Background. West Nile virus (WNV) infection in humans can result in severe, acute encephalitis typically involving subcortical gray matter brain regions. West Nile virus replication within specific human brain regions from a human case of acute encephalitis has not been studied. Methods. We describe a fatal case of WNV encephalitis in which we obtained tissue from specific brain regions at autopsy to evaluate viral-host interactions using next-generation sequencing and immunohistochemistry analysis. Results. We found that WNV populations in the injured subcortical brain regions exhibited increased amino acid variation and increased expression of specific interferon genes compared with cortical tissues despite similar viral burden. Conclusions. These observational, patient-based data suggest that neuronal injury and the strength of viral selection pressure may be associated with the level of the innate immune responses. Further studies in human and animal models evaluating the role of innate immune responses on injury patterns and viral selection pressure are needed.Entities:
Keywords: West Nile virus; apoptosis; encephalitis; interferon-stimulated genes; next-generation sequencing
Year: 2015 PMID: 26730392 PMCID: PMC4697916 DOI: 10.1093/ofid/ofv182
Source DB: PubMed Journal: Open Forum Infect Dis ISSN: 2328-8957 Impact factor: 3.835
Figure 1.Regional magnetic resonance imaging injury patterns associated with apoptosis and interferon-stimulated gene (ISG) expression. Magnetic resonance images (T2 sequences) showing increased signal intensity in the (A) midbrain substantia nigra and left mesial temporal lobe (arrows) and (B) the thalamus and right caudate nucleus (arrows). (C) Immunohistochemistry staining for cleaved-caspase 3 ([Cy3] red) and West Nile virus (WNV) envelope (ENV) antigen (TRITC, green) from indicated brain regions. Bar = 50 µm. Percentage of cells per high-power field positive for (D) CC3 and (E) WNV ENV antigen. *P < .0001, unpaired t test. (F) Reads per kilobase per million (RPKM) reads to interferon-stimulated genes from different brain regions were determined by next-generation sequencing. Gray bars indicate brain regions with neuronal injury.
Figure 2.Variations of West Nile virus (WNV) copies and population structure among brain regions. (A) WNV RNA was quantified from different brain tissues, prepared for next-generation sequencing, and (B) aligned to the WNV genome (displayed as number of aligning reads per million reads sequenced). The colored bars represent tissues with enough WNV coverage for subsequent population genetic analysis. (C) The consensus WNV sequences from each tissue were analyzed, and each line represents an amino acid change compared with the prototype strain NY99 (pink lines represent novel mutations; also see Table 1). The percentage of all sequenced WNV (D) nucleotides and (E) amino acids with substitutions were compared with published reports of WNV and dengue virus in other vertebrate samples and WNV in mosquitoes. (F) Individual intratissue WNV variants were plotted across the genome. Diamonds represent amino acid substitutions and circles represent silent mutations. *Data adapted from Grubaugh ND et al. Experimental evolution of an RNA virus in wild birds: evidence for host-dependent impacts on population structure and competitive fitness. PLoS Pathog. 2015;11:e1004874; †data adapted from Jerzak G et al. Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection. J Gen Virol. 2005;86:2175; ‡data adapted from Romano et al. Inter- and intra-host viral diversity in a large seasonal DENV2 outbreak. PLoS One. 2013;8:e70318.
WNV Amino Acid Substitutions Compared to the Prototype Strain NY99
| Strain (Source, Year, State) | Pairwise % | Nt Differences | WNV Genome Nt Position | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 268 | 1442 | 4025 | 4208 | 4294 | 4599 | 4749 | 5717 | 6350 | 7635 | 8621 | |||
| NY99 (flamingo, 1999, NY) | G | T | G | A | A | A | C | G | T | A | A | ||
| 04-214CO (human, 2004, CO) | 99.8 | 25 | ● | C | ● | ● | ● | ● | ● | ● | ● | ● | ● |
| CO5-07 (human, 2007, CO) | 99.6 | 41 | ● | C | ● | ● | ● | ● | ● | ● | ● | ● | G |
| BSL6-11 (human, 2011, MS) | 99.4 | 61 | ● | C | ● | ● | G | ● | T | ● | ● | G | ● |
| AVA1202600 ( | 99.4 | 64 | ● | C | ● | ● | ● | ● | ● | ● | ● | ● | ● |
| FtC-3699 ( | 99.4 | 64 | ● | C | ● | ● | ● | ● | ● | ● | ● | ● | ● |
| BSL2-10 (human, 2010, AZ) | 99.3 | 68 | ● | C | ● | ● | ● | ● | ● | ● | ● | G | G |
| Spinal cord/ant horn | 99.2 | 85 | A | C | A | ● | G | ●/T | A | ● | ● | G | T |
| Midbraina | A | C | A | ● | G | ●/T | – | T | ● | G | T | ||
| Thalamus | 99.2 | 85 | A | C | A | ● | G | ●/T | A | ● | ● | G | T |
| Caudatea | A | – | A | T | – | ●/T | A | ● | C | G | T | ||
| Putamena | A | – | A | ● | – | – | – | – | ●/C | – | – | ||
| Frontal cortex | 99.2 | 86 | A | C | A | ● | G | T/● | A | ● | ● | G | T |
| Polyprotein aa # | A58T | V449A | R1310K | N1371I | I1400V | Q1501H | F1551L | G1874C | H2985Q | I2513M | K2842M | ||
| Protein aa # | A58T | V159A | R167K | N228I | I26V | Q94H | F46L | G369C | H580Q | I240M | K314M | ||
| Protein | C | E | NS2A | NS2A | NS2B | NS2B | NS3 | NS3 | NS3 | NS4B | NS5 | ||
Abbreviations: aa, amino acid; AZ, Arizona; C, capsid; CO, Colorado; E, envelope; MS, Mississippi; NS, nonstructural; Nt, nucleotide; NY, New York; TX, Texas; WNV, West Nile virus; ●, ancestral nucleotide; -, missing data.
a Could not determine pairwise identity or the number of Nt differences due to incomplete coverage of the coding sequence.